Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Boyer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|April 2, 2014
ALOX12 in human toxoplasmosisWilliam H Witola, Susan Ruosu Liu, Alexandre Montpetit, et al.
Plos Neglected Tropical Diseases|June 27, 2017
Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countriesIan J Begeman, Joseph Lykins, Ying Zhou, et al.
Pediatrics|July 26, 2006
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategiesNancy Roizen, Kristen Kasza, Theodore Karrison, et al.
Plos One|June 5, 2008
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosisSarra E Jamieson, Lee-Anne de Roubaix, Mario Cortina-Borja, et al.
Scientific Reports|May 29, 2019
Publisher Correction: Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & CancerHuân M Ngô, Ying Zhou, Hernan Lorenzi, et al.
Scientific Reports|September 15, 2017
Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & CancerHuân M Ngô, Ying Zhou, Hernan Lorenzi, et al.
Current Pediatrics Reports|September 25, 2023
Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk FactorsMariangela Soberón Felín, Kanix Wang, Catalina Raggi, et al.
Current Pediatrics Reports|March 27, 2023
Building Programs to Eradicate Toxoplasmosis Part II: EducationMariangela Soberón Felín, Kanix Wang, Aliya Moreira, et al.
Current Pediatrics Reports|August 29, 2022
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and OverviewMariangela Soberón Felín, Kanix Wang, Aliya Moreira, et al.
Current Pediatrics Reports|August 22, 2022
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village"Mariangela Soberón Felín, Kanix Wang, Aliya Moreira, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|April 2, 2014
ALOX12 in human toxoplasmosisWilliam H Witola, Susan Ruosu Liu, Alexandre Montpetit, et al.
Plos Neglected Tropical Diseases|June 27, 2017
Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countriesIan J Begeman, Joseph Lykins, Ying Zhou, et al.
Pediatrics|July 26, 2006
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategiesNancy Roizen, Kristen Kasza, Theodore Karrison, et al.
Plos One|June 5, 2008
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosisSarra E Jamieson, Lee-Anne de Roubaix, Mario Cortina-Borja, et al.
Scientific Reports|May 29, 2019
Publisher Correction: Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & CancerHuân M Ngô, Ying Zhou, Hernan Lorenzi, et al.
Scientific Reports|September 15, 2017
Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & CancerHuân M Ngô, Ying Zhou, Hernan Lorenzi, et al.
Current Pediatrics Reports|September 25, 2023
Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk FactorsMariangela Soberón Felín, Kanix Wang, Catalina Raggi, et al.
Current Pediatrics Reports|March 27, 2023
Building Programs to Eradicate Toxoplasmosis Part II: EducationMariangela Soberón Felín, Kanix Wang, Aliya Moreira, et al.
Current Pediatrics Reports|August 29, 2022
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and OverviewMariangela Soberón Felín, Kanix Wang, Aliya Moreira, et al.
Current Pediatrics Reports|August 22, 2022
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village"Mariangela Soberón Felín, Kanix Wang, Aliya Moreira, et al.
Pageof 2